Azur Pharma, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey (NCT00683891) | Azur Pharma, Inc |
Track Azur Pharma, Inc automatically
Every clearance here is in the API, with alerts when new ones post.